Skip to content

Author

Daniel Ebrahimi-Fakhari

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Isavuconazole: Real-World Data and Clinical Considerations for Pediatric Patients.

Isavuconazole (ISAV) is a broad-spectrum triazole antifungal approved for the treatment of invasive aspergillosis and mucormycosis and has recently received approval for use in children ≥1 year of age. Pediatric approval was based on limited registration data, underscoring the importance of real-world evidence to bette...

Lorenzo Chiusaroli, Danila Seidel, Daniel Ebrahimi-Fakhari et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.